Nanocurcumin was linked to better disability scores in small RRMS trials, but researchers say larger studies are needed.

P&G, Unilever and Mondelez are using AI to formulate products and run campaigns, compressing timelines that once took years into weeks.

DXC Technology stock remains a "Buy" given its AI-driven growth (OASIS), cost optimization, and FY2029 margin expansion.

Lore De Valck is a Programme Manager at biotope by VIB, an early-stage investor and accelerator supporting biotech startups ...

John Steenhuisen's fire-bombing of the DA was a ransom demand. Unless the party negotiates a ceasefire, he can - and will - ...

The Beijing Winter Olympics Park, which hosts the Games' organizing committee, operating center, the Big Air Shougang ski ...

An online survey of 1,436 patients with rheumatic disease revealed “significant variability” in cannabis products used, ...

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

Now, as both nations step into 2026 under the banner of the "China-Africa Year of Cultural and People-to-People Exchanges", ...

More light whiskey is appearing on shelves than ever before-but what actually is it, and why did a spirit invented to save ...

We met the man with the best job in concrete to find out about the most promising decarbonisation technologies from 3D ...

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio ("Myricx") has reached agreement to be acquired by Novartis, for up to ...